Adherence Assessment to Highly Active Antiretroviral Therapy
- 1 March 2001
- journal article
- review article
- Published by Mary Ann Liebert Inc in AIDS Patient Care and STDs
- Vol. 15 (3), 109-115
- https://doi.org/10.1089/108729101750123544
Abstract
Adherence to highly active antiretroviral therapy (HAART) is the outcome of a dynamic process of clinical and behavioral interactions. This article reviews factors influencing this process and provides suggestions to enhance adherence to HAART. Interventions to improve adherence to HAART should combine efficacy of treatments with a strong patient-provider alliance and cognitive behavioral interventions.Keywords
This publication has 36 references indexed in Scilit:
- Transmission of antiretroviral-drug-resistant HIV-1 variantsThe Lancet, 1999
- Rethinking Nonadherence: Historical Perspectives on Triple-Drug Therapy for HIV DiseaseAnnals of Internal Medicine, 1998
- The Era of Adherence to HIV TherapyAnnals of Internal Medicine, 1998
- Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral TherapyScience, 1997
- Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panelPublished by American Medical Association (AMA) ,1997
- Hidden dangers of incompletely suppressive antiretroviral therapyThe Lancet, 1997
- Adherence in AIDS clinical trials: A framework for clinical research and clinical careJournal of Clinical Epidemiology, 1997
- HIV-1 protease inhibitors. A review for cliniciansJAMA, 1997
- Ordered accumulation of mutations in HIV protease confers resistance to ritonavirNature Medicine, 1996
- Compliance with drug treatment.BMJ, 1981